Business Context and Reporting Period
This Form 8-K Current Report was filed by Modular Medical, Inc. (Nasdaq: MODD) on March 26, 2026. The report details a material corporate action involving a reverse stock split approved by shareholders and the board of directors.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on corporate governance and capital structure adjustments.
Material Changes
- Reverse Stock Split: The Company effected a 1-for-30 reverse stock split of its common stock.
- Effective Date: The split became effective at 5:30 a.m. Eastern Time on March 31, 2026.
- Trading Status: Post-split trading commenced on March 31, 2026, under CUSIP number 60785L306.
- Authorized Shares: The number of authorized shares and par value ($0.001) remain unchanged.
- Equity Adjustments: Outstanding equity awards, reserved shares, and warrants were adjusted by dividing share counts by 30 and multiplying exercise prices by 30.
- Fractional Shares: No fractional shares were issued; holders received cash in lieu of fractional shares.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard incorporation by reference of the Certificate of Amendment. The primary event is the structural adjustment of the Company's equity.
Investor Verification Checklist
- Verify the post-split share count and adjusted exercise prices for any held options or warrants.
- Confirm receipt of cash payments for any fractional shares resulting from the 1-for-30 split.
- Check the new CUSIP number (60785L306) for accurate trading and settlement.
- Review the full text of the Certificate of Amendment (Exhibit 3.1) for any additional terms not summarized here.